Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study-Reference-Cited by-同舟云学术

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study

Published:2021-09-04 Issue:12 Volume:76 Page:3814-3817
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Bakker Daphne S.¹²^ORCID,ter Linde José J. M.²,Amini Mojtaba M.³,Ariëns Lieneke F. M.¹^ORCID,van Luijk Chantal M.⁴,de Bruin‐Weller Marjolein S.¹^ORCID,Thijs Judith L.¹^ORCID,Vercoulen Yvonne³^ORCID,van Wijk Femke²

Affiliation:

1. Department of Dermatology and Allergology National Expertise Center for Atopic Dermatitis University Medical Center Utrecht Utrecht The Netherlands

2. Center for Translational Immunology University Medical Center Utrecht Utrecht The Netherlands

3. Center for Molecular Medicine University Medical Center Utrecht Utrecht University Utrecht The Netherlands

4. Department of Ophthalmology University Medical Center Utrecht Utrecht The Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15064

Reference7 articles.

1. Conjunctivitis in dupilumab clinical trials

2. Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis